Advances in Immunotherapy for Cancer Treatment: Targeting the Immune System to Fight Tumors

Sanjay Kumar Kulkarni

doi:10.36676/urr.v11.i3.1286

Authors

Dr. Sanjay Kumar Kulkarni Neurosurgeon at Christian Medical College (CMC), Vellore

DOI:

https://doi.org/10.36676/urr.v11.i3.1286

Keywords:

Cancer, Treatment, Targeting, Immune System

Abstract

Immunotherapy has emerged as a ground-breaking approach in the treatment of cancer, harnessing the power of the immune system to target and destroy tumor cells. This paper provides an overview of recent advances in immunotherapy and its role in combating cancer. Various immunotherapeutic strategies, including checkpoint inhibitors, CAR T-cell therapy, TIL therapy, cancer vaccines, immune checkpoint combination therapy, and bispecific antibodies, are discussed in detail, highlighting their mechanisms of action and clinical applications. Key advancements in the field, supported by clinical evidence and case studies, underscore the remarkable efficacy of immunotherapy in treating a wide range of cancers.

References

Dr Ritesh, Kumar , D. S., & Dr Shital Chinchalkar. (2018). Role of sleep-in immunity: Ayurveda perspective. Innovative Research Thoughts, 4(3), 422–426. Retrieved from https://irt.shodhsagar.com/index.php/j/article/view/1361

Dr.Siddharth Bindroo, & Dr. S.K.Wamgoo. (2016). Diabetes And Effect On Functioning Of Various Organs Of Human Body . International Journal for Research Publication and Seminar, 7(1). Retrieved from https://jrps.shodhsagar.com/index.php/j/article/view/797

Gracy Singh. (2022). Study of Vaccination is types and working over Immune system of Human Body. International Journal for Research Publication and Seminar, 13(2), 184–192. Retrieved from https://jrps.shodhsagar.com/index.php/j/article/view/589

Havel, J. J., Chowell, D., & Chan, T. A. (2019). The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy. Nature Reviews Cancer, 19(3), 133-150.

Hellmann, M. D., & Paz-Ares, L. (2018). Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer. New England Journal of Medicine, 379(22), 2108-2121.

Hellmann, M. D., Ciuleanu, T. E., & Pluzanski, A. (2018). Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden. New England Journal of Medicine, 378(22), 2093-2104.

June, C. H., & Sadelain, M. (2018). Chimeric Antigen Receptor Therapy. New England Journal of Medicine, 379(1), 64-73.

Katragadda, V. . (2024). Leveraging Intent Detection and Generative AI for Enhanced Customer Support. Journal of Artificial Intelligence General Science (JAIGS) ISSN:3006-4023, 5(1), 109–114. https://doi.org/10.60087/jaigs.v5i1.178

Lumley, M. A., Osoba, D., & Stockler, M. R. (2019). Quality of life impact of sipuleucel-T for asymptomatic or minimally symptomatic metastatic castrate-resistant prostate cancer. Journal of Clinical Oncology, 37(14), 1192-1201.

Maude, S. L., & Laetsch, T. W. (2020). Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. New England Journal of Medicine, 378(5), 439-448.

Ms Shelly. (2017). Current Scenario of Regulatory Affairs In Pharmaceutical Education Sector -A review. Innovative Research Thoughts, 3(9), 145–154. Retrieved from https://irt.shodhsagar.com/index.php/j/article/view/246

Ms Shelly. (2017). Who Benefit From Essential Drug Price Control, Need of Price Control In India -A review. Innovative Research Thoughts, 3(9), 155–163. Retrieved from https://irt.shodhsagar.com/index.php/j/article/view/247

Ott, P. A., Hu, Z., & Keskin, D. B. (2017). An immunogenic personal neoantigen vaccine for patients with melanoma. Nature, 547(7662), 217-221.

Preeti sai. (2024). Plant-Based methods for boosting immunity. Universal Research Reports, 11(1), 1–24. Retrieved from https://urr.shodhsagar.com/index.php/j/article/view/1176

Ravina Parihar, & Dr. Sourabh Sharma. (2024). Role of regulatory affairs in ensuring quality and safety of pharmaceutical products. Universal Research Reports, 11(2), 55–67. Retrieved from https://urr.shodhsagar.com/index.php/j/article/view/1254

Rosenberg, S. A., & Restifo, N. P. (2015). Adoptive cell transfer as personalized immunotherapy for human cancer. Science, 348(6230), 62-68.

Rhythm khanna, & Dr. Surya Prakash Gautam. (2016). A review paper on Targeted Drug Delivery Methods and their use. International Journal for Research Publication and Seminar, 7(2). Retrieved from https://jrps.shodhsagar.com/index.php/j/article/view/759

Sahin, U., Derhovanessian, E., Miller, M., Kloke, B. P., & Simon, P. (2017). Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature, 547(7662), 222-226.

Satyanarayan Kanungo, Amrendra Kumar & Rajendra Zagade (2022). OPTIMIZING ENERGY CONSUMPTION FOR IOT IN DISTRIBUTED COMPUTING. International Journal of Emerging Technologies and Innovative Research, 9(6), k514-k522

Sharma, P., & Allison, J. P. (2015). The future of immune checkpoint therapy. Science, 348(6230), 56-61.

Yashpal, & Deepika Mahal. (2018). INVESTIGATING BRUTEFORCE AND TIMING ATTACK IMMUNITY IN PROPOSED WORK. International Journal for Research Publication and Seminar, 9(4), 27–36. Retrieved from https://jrps.shodhsagar.com/index.php/j/article/view/1345